These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
23. Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells. Yang X; He G; Gong Y; Zheng B; Shi F; Shi R; Yang X Eur J Haematol; 2014 Feb; 92(2):111-20. PubMed ID: 24112092 [TBL] [Abstract][Full Text] [Related]
24. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells. Airiau K; Prouzet-Mauléon V; Rousseau B; Pigneux A; Jeanneteau M; Giraudon M; Allou K; Dubus P; Belloc F; Mahon FX Oncotarget; 2016 Jan; 7(1):845-59. PubMed ID: 26625317 [TBL] [Abstract][Full Text] [Related]
25. Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells. Negi SS; Brown P Oncotarget; 2015 Oct; 6(33):34846-58. PubMed ID: 26472108 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Zhao J; Niu X; Li X; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Ge Y Oncotarget; 2016 Jun; 7(23):34785-99. PubMed ID: 27166183 [TBL] [Abstract][Full Text] [Related]
27. Original research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties. Ballazhi L; Imeri F; Jashari A; Popovski E; Stojković G; Dimovski AJ; Mikhova B; Mladenovska K Acta Pharm; 2017 Mar; 67(1):35-52. PubMed ID: 28231049 [TBL] [Abstract][Full Text] [Related]
28. Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells. Opydo-Chanek M; Rak A; Cierniak A; Mazur L Toxicol In Vitro; 2017 Aug; 42():38-46. PubMed ID: 28366708 [TBL] [Abstract][Full Text] [Related]
29. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549. Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186 [TBL] [Abstract][Full Text] [Related]
31. The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells. Goto S; Goto H; Yokosuka T Int J Hematol; 2016 May; 103(5):572-83. PubMed ID: 26886449 [TBL] [Abstract][Full Text] [Related]
32. [Synergistic antileukemic effect of phytoestrogens and chemotherapeutic drugs on leukemic cell lines in vitro]. Shen J; Zhang WJ; Tai YC; Wong CH; Xie Z; Chen CS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):276-81. PubMed ID: 18426648 [TBL] [Abstract][Full Text] [Related]
33. Synergism between arsenite and proteasome inhibitor MG132 over cell death in myeloid leukaemic cells U937 and the induction of low levels of intracellular superoxide anion. Lombardo T; Cavaliere V; Costantino SN; Kornblihtt L; Alvarez EM; Blanco GA Toxicol Appl Pharmacol; 2012 Feb; 258(3):351-66. PubMed ID: 22178740 [TBL] [Abstract][Full Text] [Related]
34. Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells. Ivanov VN; Zhou H; Hei TK Cancer Res; 2007 Jun; 67(11):5397-407. PubMed ID: 17545621 [TBL] [Abstract][Full Text] [Related]
35. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262 [TBL] [Abstract][Full Text] [Related]
36. Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia. Goto H; Yanagimachi M; Goto S; Takeuchi M; Kato H; Yokosuka T; Kajiwara R; Yokota S Anticancer Drugs; 2012 Apr; 23(4):417-25. PubMed ID: 22205153 [TBL] [Abstract][Full Text] [Related]
37. The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines. Visco C; Castegnaro S; Chieregato K; Bernardi M; Albiero E; Zanon C; Madeo D; Rodeghiero F Blood Cells Mol Dis; 2012 Jan; 48(1):68-75. PubMed ID: 22036761 [TBL] [Abstract][Full Text] [Related]
38. G2/M Cell Cycle Arrest and Tumor Selective Apoptosis of Acute Leukemia Cells by a Promising Benzophenone Thiosemicarbazone Compound. Cabrera M; Gomez N; Remes Lenicov F; Echeverría E; Shayo C; Moglioni A; Fernández N; Davio C PLoS One; 2015; 10(9):e0136878. PubMed ID: 26360247 [TBL] [Abstract][Full Text] [Related]
39. Synergistic Cytotoxicity of Melatonin and New-generation Anticancer Drugs Against Leukemia Lymphocytes But Not Normal Lymphocytes. Zhelev Z; Ivanova D; Bakalova R; Aoki I; Higashi T Anticancer Res; 2017 Jan; 37(1):149-159. PubMed ID: 28011485 [TBL] [Abstract][Full Text] [Related]
40. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia. Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]